AbbVie Revenue Rises on Immunology Growth

Date:

February 4, 2026

AbbVie posted higher fourth-quarter revenue on the back of growth from its immunology portfolio, led by arthritis and Crohn’s disease drugs Skyrizi and Rinvoq.

Source link

How Patriots’ Super Bowl run mirrors team that launched New England’s dynasty

Hardy Says He’d ‘Love’ to Do a Full ‘McArthur’ Collab Album

1newsmedia.com https://1newsmedia.com

Popular

AbbVie Revenue Rises on Immunology Growth

Subscribe

Opinion | Is New York Stuck With Kathy Hochul?

Jameis Winston benched: J.J. McCarthy sparks Giants, but comeback falls just short

Egypt’s top security body agrees to help Saudi Arabia defend itself against Houthi attacks

APD investigating crash near Kirtland Air Force Base, motorcyclist hospitalized in 'critical condition'

Travis Hunter has interception, TD catch in Jaguars’ loss

More like this
Related

Opinion | Is New York Stuck With Kathy Hochul?

Jameis Winston benched: J.J. McCarthy sparks Giants, but comeback falls just short

Egypt’s top security body agrees to help Saudi Arabia defend itself against Houthi attacks

APD investigating crash near Kirtland Air Force Base, motorcyclist hospitalized in 'critical condition'

About us

The latest

Opinion | Is New York Stuck With Kathy Hochul?

Jameis Winston benched: J.J. McCarthy sparks Giants, but comeback falls just short

Egypt’s top security body agrees to help Saudi Arabia defend itself against Houthi attacks

AbbVie Revenue Rises on Immunology Growth

Subscribe

More like thisRelated

About us

The latest

More like this
Related